119-hr1947

HR
✓ Complete Data

TREAT PTSD Act

Login to track bills
Introduced:
Mar 6, 2025
Policy Area:
Armed Forces and National Security

Bill Statistics

5
Actions
12
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Mar 27, 2025
Referred to the Subcommittee on Health.

Actions (5)

Referred to the Subcommittee on Health.
Type: Committee | Source: House committee actions | Code: H11000
Mar 27, 2025
Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Mar 6, 2025
Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Mar 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Mar 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Mar 6, 2025

Subjects (1)

Armed Forces and National Security (Policy Area)

Text Versions (1)

Introduced in House

Mar 6, 2025

Full Bill Text

Length: 5,653 characters Version: Introduced in House Version Date: Mar 6, 2025 Last Updated: Nov 14, 2025 6:20 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1947 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 1947

To direct the Secretary of Veterans Affairs and the Secretary of
Defense to furnish stellate ganglion block to veterans and members of
the Armed Forces with post-traumatic stress disorder, and for other
purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 6, 2025

Mr. Perry (for himself, Mr. Ogles, Mr. Gosar, Mr. Nehls, Mr. Crenshaw,
Mr. McCormick, Mr. Fitzpatrick, and Mr. Valadao) introduced the
following bill; which was referred to the Committee on Armed Services,
and in addition to the Committee on Veterans' Affairs, for a period to
be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned

_______________________________________________________________________

A BILL

To direct the Secretary of Veterans Affairs and the Secretary of
Defense to furnish stellate ganglion block to veterans and members of
the Armed Forces with post-traumatic stress disorder, and for other
purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Treatment and Relief through
Emerging and Accessible Therapy for PTSD Act'' or the ``TREAT PTSD
Act''.
SEC. 2.
THE ARMED FORCES WITH POST-TRAUMATIC STRESS DISORDER.

(a) Provision to Veterans.--

(1) In general.--Subchapter II of chapter 17 of title 38,
United States Code, is amended by adding at the end the
following new section:
``
Sec. 1720M.
``

(a) In General.--The Secretary shall furnish stellate ganglion
block to any veteran who--
``

(1) is enrolled in the patient enrollment system under
section 1705 of this title; `` (2) has been diagnosed with post-traumatic stress disorder; and `` (3) has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block.
``

(2) has been diagnosed with post-traumatic stress
disorder; and
``

(3) has elected to receive stellate ganglion block after
being informed by a qualified health care provider of the risks
and benefits of stellate ganglion block.
``

(b) Provision of Care.--The Secretary may furnish stellate
ganglion block under subsection

(a) through a medical facility of the
Department or through a health care provider specified in
section 1703 (c) of this title.
(c) of this title.''.

(2) Clerical amendment.--The table of contents at the
beginning of chapter 17 of title 38, United States Code, is
amended by inserting after the item relating to
section 1720L the following new item: ``1720M.
the following new item:

``1720M. Provision of stellate ganglion block for certain veterans.''.

(b) Provision to Members of the Armed Forces.--

(1) In general.--Chapter 55 of title 10, United States
Code, is amended by inserting after
section 1074o the following new section: ``
new section:
``
Sec. 1074p.
``

(a) In General.--The Secretary shall furnish stellate ganglion
block to any member of the Armed Forces (including the reserve
components) who is performing or has performed active service and who--
``

(1) is enrolled in the TRICARE program under chapter 55
of this title;
``

(2) has been diagnosed with post-traumatic stress
disorder; and
``

(3) has elected to receive stellate ganglion block after
being informed by a qualified health care provider of the risks
and benefits of stellate ganglion block.
``

(b) Provision of Care.--The Secretary may furnish stellate
ganglion block under subsection

(a) through a medical facility of the
Department or through a qualified health care provider participating in
a Department administered TRICARE health insurance program.''.

(2) Clerical amendment.--The table of contents at the
beginning of chapter 55 of title 10, United States Code, is
amended by inserting after the item relating to
section 1074o the following new item: ``1074p.
the following new item:

``1074p. Provision of stellate ganglion block for certain members.''.
(c) Update of Joint Clinical Practice Guideline.--

(1) Update of guideline.--Not later than 180 days after the
date of the enactment of this Act, the Secretary of Veterans
Affairs and the Secretary of Defense shall update the guideline
published jointly by the Secretaries and titled the ``VA/DOD
Clinical Practice Guideline

(CPG) for the Management of PTSD''
(or such successor guideline) to ensure the guideline--
(A) reflects the availability of stellate ganglion
block as a therapy option; and
(B) includes information on the clinical indicators
and contraindicators for such therapy option.

(2) Notification.--Upon updating the guideline under
paragraph

(1) , the Secretaries shall notify the appropriate
congressional committees of such update.

(3) Appropriate congressional committees defined.--In this
subsection, the term ``appropriate congressional committees''
means--
(A) the congressional defense committees (as such
term is defined in
section 101 of title 10, United States Code); and (B) the Committees on Veterans' Affairs of the House of Representatives and the Senate.
States Code); and
(B) the Committees on Veterans' Affairs of the
House of Representatives and the Senate.
(d) Effective Date.--The amendments made by subsections

(a) and

(b) shall take effect on the date that is 180 days after the date of the
enactment of this Act.
<all>